A Merry Dickensian Christmas from @urology_history - Charles Dickens suffered with ureteric colic for most of his life. He took hydrocyanic acid, laudanum and henbane for he spasm and pain and wore a broad flannel belt around his waist. pic @DickensMuseum
'Treatment rates of prostate cancer were higher in the US compared to England raising potential over-treatment concerns for low-risk disease (CPG1) in the US and under-treatment of clinically significant disease (CPG3-5) in England', via @mparry7 et al
We are excited to welcome Dr Alison Tree to the National Prostate Cancer Audit as the Clinical Lead for Oncology.
Alison joins us from The Royal Marsden NHS Foundation Trust where she is a Consultant clinical oncologist. You can follow Alison on @alison_tree
The National Prostate Cancer Audit's investigation of the organisation & delivery of supportive services for patients with prostate cancer in the NHS in England and Wales is in @BMJ_Open. @JoannaDodkins @JanvanderMeule6 @AggarwalOnc@GUresearch_MCR
https://t.co/vh9kz8MyDC
Delighted to announce a clinical fellowship in radiorecurrent prostate cancer at UCL/UCLH with @susan_heavey@gland_ambition in @UCLDivofSurgery! PhD funding included & opportunity to develop some very exciting work! Suitable for urologists and oncologists https://t.co/CTssCFULhU
📢 Exciting times at NATCAN as we welcome our new Clinical Director, Dr Ajay Aggarwal. Take a look at the full announcement on our website 📢 #NATCAN https://t.co/iUPASlVyXS
@AggarwalOnc@LSHTM@HQIP@NHSEngland
Delighted to have been appointed Clinical Director of the National Cancer Audits in England and Wales. I look forward to working with clinical, policy and patient communities to drive improvements in the quality and experience of cancer care across the nine cancers.
💡 Collecting RCT data can be expensive and time-consuming. What if there's a more efficient way?
Learn how routine hospital administrative data can revolutionise clinical trials
https://t.co/rbUZ2bG3Ib
@mattsydes@Prof_Nick_James@OncoAlert@HattieMintz
🚀 Seeking cost-effective and efficient ways to run clinical trials?
Discover the power of routinely collected hospital administrative data in improving trial design, patient experience, and resource allocation
https://t.co/rbUZ2bG3Ib
@OncoAlert@mattsydes@Prof_Nick_James
@sacosw@Liz_ORiordan@NHSEngland Gender disparity persists in the UK surgical workforce and there are significant differences between surgical specialties esp' Vascular Surgery, Cardiothoracic Surgery, Neurosurgery & Trauma and Orthopaedics.
https://t.co/MV0jr2bFXm via @mparry7 et al
Any urology trainee with a sub-specialty interest in kidney cancer should definitely apply! Access to huge national datasets with opportunities for MD/PhD in surgical outcomes research. Data ready to be analysed with scope for big output (if the @NPCA_uk is anything to go by)!
Radical Tx of CPG1 (low risk) 38% in 🇺🇸 vs 14% in 🏴 - I don't think the problem is what you call it but where your managed😏 - Comparison of the treatment of men with prostate cancer between the US and England: an international population-bas… https://t.co/drCvsat1iI
📢📢📢 CALLING ONCOLOGY COLLEAGUES
👀 Clinical Fellowship Opportunities to support the National Kidney Cancer Audit
More info:
Kidney Cancer fellow: https://t.co/OlPVgl07yR
NATCAN clinical fellows - https://t.co/BaNIGLTxcr
DEADLINE: 25 June
@jonathananing@grantissimus
New Competition. RT and follow (if you haven't already) to win this 12 x 8 inch Canning Dock, #Liverpool at Dawn print. The draw will be on Sunday, 21st May 2023.
Thank you Chicago for an incredible #AUA2023!
In case you missed it, I was fortunate to present data from #STAMPEDE on clinical fractures and risk reduction with zoledronic acid.
@MRCCTU @Prof_Nick_James@GUresearch_MCR